Competing Interests
A. O’Rourke
Jeffrey M. Peppercorn has received research funding from Outcomes4Me Inc., consulted for Abbott Labs and reports a family member employed by GlaxoSmithKline. Maya R. Said is an employee and has ownership interest in Outcomes4Me Inc. Eva Glieberman is an employee of Outcomes4Me Inc. Emily A. O’Rourke is an employee and has ownership interest in Outcomes4Me Inc. Amanda Stroiney is an employee and has ownership interest in Outcomes4Me Inc. Aditya Bardia has received research funding from Genentech, Novartis, Pfizer, Merck, Sanofi, Radius Health, Immunomedics, Gilead, Daiichi Pharma, Astra Zeneca, and Eli Lilly, and has consulted for Pfizer, Novartis, Genentech, Merck, Radius Health, Immunomedics, Gilead, Sanofi, Daiichi Pharma, Astra Zeneca, Phillips, Eli Lilly, Foundation Medicine. Laura Spring has received research funding from Merck, Phillips, and Eli Lilly, and has consulted for Novartis and Puma. Steven J Isakoff has received research funding from Abbvie, Astra Zeneca, Genentech, Merck, and OncoPep, and has consulted for Seattle Genetics, Novartis, Paxman, and Puma, and reports a family member employed by Merus NV. Agnes H. Kwak, Beverly Moy, and Nora Horick declare no relevant competing financial interests.